Literature DB >> 18251786

Differences in the immunolocalization of surfactant protein (SP)-A, SP-D, and KL-6 in pulmonary alveolar proteinosis.

Makoto Kobayashi1, Tamotsu Takeuchi, Yuji Ohtsuki.   

Abstract

Idiopathic pulmonary alveolar proteinosis (PAP) is a rare lung disorder characterized by excessive accumulation of surfactant lipoprotein in alveoli, which is caused by autoantibody against granulocyte-macrophage colony-stimulating factor. The case of a 42-year-old man with idiopathic PAP, who had worked in steel and cement plants for the past 10 years, is presented. His serum anti-GM-CSF antibody level was markedly increased. Lung specimens obtained during video-assisted thoracoscopic surgery were examined on immunohistochemistry using mAb for localization of surfactant proteins A and D (SP-A and SP-D) and a mucin-like protein, KL-6. Furthermore, western blot analysis of his bronchoalveolar lavage fluid (BALF) was performed using anti-SP-A and anti-SP-D mAb. As well as KL-6, SP-A was localized in the intra-alveolar fine granular substances. But on HE staining the SP-D was localized in SP-A-negative foci corresponding to eosinophilic large globules that were surrounded by an SP-A-positive fine granular structure. On western blot the specificity of mAb was shown. In conclusion, this is the first report demonstrating the striking difference in the distribution of SP-A and SP-D in the intra-alveolar substance of a patient with idiopathic PAP.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18251786     DOI: 10.1111/j.1440-1827.2007.02212.x

Source DB:  PubMed          Journal:  Pathol Int        ISSN: 1320-5463            Impact factor:   2.534


  7 in total

1.  Atypical pulmonary alveolar proteinosis presenting as a mixed nodular ground-glass opacity with focal mucinosis mimicking lung cancer.

Authors:  Tsutomu Shinohara; Hiroyuki Hino; Shino Imanishi; Keishi Naruse; Yuji Ohtsuki; Fumitaka Ogushi
Journal:  J Thorac Dis       Date:  2018-09       Impact factor: 2.895

2.  Spontaneous pulmonary alveolar proteinosis in captive "moustached tamarins" (Saguinus mystax).

Authors:  C R Michaud; D R Ragland; K I Shea; P M Zerfas; R J Kastenmayer; M C St Claire; W R Elkins; A S Gozalo
Journal:  Vet Pathol       Date:  2011-07-06       Impact factor: 2.221

3.  Clinical significance of serum lipids in idiopathic pulmonary alveolar proteinosis.

Authors:  Cun S Fang; Ying C Wang; Tao H Zhang; Jing Wu; Wei Wang; Chun Wang; Ming Y Zhang
Journal:  Lipids Health Dis       Date:  2012-01-17       Impact factor: 3.876

4.  An exploratory study investigating biomarkers associated with autoimmune pulmonary alveolar proteinosis (aPAP).

Authors:  Ilaria Campo; Federica Meloni; Martina Gahlemann; Wiebke Sauter; Carina Ittrich; Corinna Schoelch; Bruce C Trapnell; Abhya Gupta
Journal:  Sci Rep       Date:  2022-05-24       Impact factor: 4.996

Review 5.  Pulmonary surfactant: an immunological perspective.

Authors:  Zissis C Chroneos; Zvjezdana Sever-Chroneos; Virginia L Shepherd
Journal:  Cell Physiol Biochem       Date:  2009-12-22

6.  Serum KL-6 is a predictor of outcome in pulmonary alveolar proteinosis.

Authors:  Francesco Bonella; Shinichiro Ohshimo; Cai Miaotian; Matthias Griese; Josune Guzman; Ulrich Costabel
Journal:  Orphanet J Rare Dis       Date:  2013-04-04       Impact factor: 4.123

7.  Subclinical interstitial lung damage in workers exposed to indium compounds.

Authors:  Sungyeul Choi; Yong-Lim Won; Dohyung Kim; Gwang-Yong Yi; Jai-Soung Park; Eun-A Kim
Journal:  Ann Occup Environ Med       Date:  2013-10-21
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.